<SEC-DOCUMENT>0001610618-19-000036.txt : 20190509
<SEC-HEADER>0001610618-19-000036.hdr.sgml : 20190509
<ACCEPTANCE-DATETIME>20190509161946
ACCESSION NUMBER:		0001610618-19-000036
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20190509
DATE AS OF CHANGE:		20190509
EFFECTIVENESS DATE:		20190509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cidara Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001610618
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				461537286
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-231326
		FILM NUMBER:		19810837

	BUSINESS ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-752-6170

	MAIL ADDRESS:	
		STREET 1:		6310 NANCY RIDGE DRIVE
		STREET 2:		SUITE 101
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	K2 THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20140611
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>cdtxs-82019x05x09.htm
<DESCRIPTION>FORM S-8
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s88EC243BC9CD51BCAFFAC9598F184FBC"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;-sec-extract:summary;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">As filed with the Securities and Exchange Commission on </font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">May&#160;9, 2019</font><font style="font-family:inherit;font-size:8pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Registration No.&#160;333-</font></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:1px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><hr></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Washington, D.C. 20549</font><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:1px;text-align:center;"><hr></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">FORM S-8</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</font><font style="font-family:inherit;font-size:4pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:1px;text-align:center;"><hr></div><div style="line-height:120%;padding-bottom:1px;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font><font style="font-family:inherit;font-size:16pt;font-weight:bold;">CIDARA THERAPEUTICS, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)</font></div><div style="line-height:120%;padding-bottom:1px;text-align:center;"><hr></div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:49%;"></td><td style="width:2%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Delaware</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">46-1537286</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(State or other jurisdiction of incorporation or organization)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(I.R.S. Employer Identification No.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:49%;"></td><td style="width:2%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">6310 Nancy Ridge Drive, Suite 101</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">San Diego, California</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">92121</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Address of Principal Executive Offices)</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Zip Code)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;"><hr></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015 Equity Incentive Plan</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015 Employee Stock Purchase Plan</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Full titles of the plans)</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;padding-bottom:1px;text-align:center;"><hr></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Jeffrey Stein, Ph.D.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">President and Chief Executive Officer</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cidara Therapeutics, Inc.</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6310 Nancy Ridge Drive, Suite 101</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">San Diego, California 92121</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(858) 752-6170</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;"><hr></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-style:italic;">Copies to:</font></div><div style="line-height:120%;text-align:center;font-size:9pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charles J. Bair, Esq.</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Karen E. Deschaine, Esq.</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cooley LLP</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">4401 Eastgate Mall</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">San Diego, California 92121</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(858)&#160;550-6000</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;Jeffrey Stein, Ph.D.</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">President and Chief Executive Officer</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Cidara Therapeutics, Inc.</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6310 Nancy Ridge Drive, Suite 101</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">San Diego, California 92121</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(858) 752-6170</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:4pt;">&#160;</font><font style="font-family:inherit;font-size:9pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:53%;"></td><td style="width:1%;"></td><td style="width:21%;"></td><td style="width:1%;"></td><td style="width:3%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Large&#160;Accelerated&#160;filer</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:Wingdings;font-size:7pt;">o</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Accelerated&#160;filer</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:Wingdings;font-size:7pt;">x</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Non-accelerated filer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:Wingdings;font-size:7pt;">o</font><font style="font-family:inherit;font-size:7pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Smaller&#160;reporting&#160;company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:Wingdings;font-size:7pt;">x</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Emerging growth company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:Wingdings;font-size:7pt;">x</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:5px;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. </font><font style="font-family:Wingdings;font-size:7pt;">o</font></div><div style="line-height:120%;text-align:left;"><hr></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;">&#160;</font></div><div style="line-height:120%;padding-top:5px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">CALCULATION OF REGISTRATION FEE</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="10"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td><td style="width:13%;"></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Title of securities</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">to be registered</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Amount</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">to be</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">registered (1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Proposed</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">maximum</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">offering&#160;price</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">per share (2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Proposed</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">maximum</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">aggregate</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">offering price (2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Amount of</font></div><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">registration fee</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-left:10px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015 Equity Incentive Plan</font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Common Stock, $0.0001 par value per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">1,112,640 shares (3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$2.27</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$2,525,693</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$307</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="padding-left:10px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2015 Employee Stock Purchase Plan</font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Common Stock, $0.0001 par value per share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">278,160 shares (4)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$2.27</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$631,424</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">$77</font></div></td></tr><tr><td colspan="10" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:3pt;"><font style="font-family:inherit;font-size:3pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:4%;"></td><td style="width:96%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(1)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), this Registration Statement shall also cover any additional shares of the Registrant&#8217;s Common Stock (&#8220;Common Stock&#8221;) that become issuable under the plans by reason of any stock dividend, stock split, recapitalization or other similar transaction.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(2)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">This estimate is made pursuant to Rule 457(c) and Rule 457(h)(1) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based on the average of the high and low prices of the Common Stock as reported on the Nasdaq Global Market on May 8, 2019.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(3)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Cidara Therapeutics, Inc. 2015 Equity Incentive Plan (the &#8220;2015 Plan&#8221;) on January 1, 2019 pursuant to an &#8220;evergreen&#8221; provision contained in the 2015 Plan. Pursuant to such provision, on January&#160;1 of each calendar year through 2025, the number of shares authorized for issuance under the 2015 Plan is automatically increased by a number equal to the lesser of: (a)&#160;4% of the total number of shares of capital stock outstanding on December&#160;31 of the preceding calendar year; or (b)&#160;such lesser number of shares of Common Stock as is determined by the Registrant&#8217;s board of directors (the &#8220;Board&#8221;) for the applicable year.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(4)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Represents shares of Common Stock that were automatically added to the shares authorized for issuance under the Cidara Therapeutics, Inc. 2015 Employee Stock Purchase Plan (the &#8220;2015 ESPP&#8221;) on January 1, 2019 pursuant to an &#8220;evergreen&#8221; provision contained in the 2015 ESPP. Pursuant to such provision, on January&#160;1 of each calendar year through 2025, the number of shares authorized for issuance under the 2015 ESPP is automatically increased by a number equal to the lesser of: (a)&#160;1% of the total number of shares of capital stock outstanding on December&#160;31 of the preceding calendar year; (b)&#160;490,336 shares; or (c)&#160;a lesser number of shares of Common Stock as is determined by the Board that is less than (a)&#160;and (b).</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;text-align:left;"><hr></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">INCORPORATION BY REFERENCE OF CONTENTS OF REGISTRATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">STATEMENTS ON FORM S-8</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:17px;text-align:justify;text-indent:52px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">This Registration Statement on Form S-8 is being filed for the purpose of increasing the number of securities of the same class as other securities for which a Registration Statement on Form&#160;S-8 relating to the same benefit plans is effective.&#160;&#160;</font></div><div style="line-height:120%;padding-bottom:17px;text-align:justify;text-indent:52px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Registrant&#8217;s Registration Statements on Form&#160;S-8 previously filed with the Securities and Exchange Commission on April 15, 2015 (File No.&#160;333-203434), March 18, 2016 (File No. 333-210263), March 15, 2017 (File No. 333-216722) and November 8, 2018 (File No. 333-228282) are incorporated by reference in this Registration Statement, pursuant to General Instruction E to Form&#160;S-8. </font></div><div style="line-height:120%;text-align:left;"><hr></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:7%;"></td><td style="width:2%;"></td><td style="width:91%;"></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">ITEM&#160;8. EXHIBITS.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Exhibit</font></div><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">Description</font><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000119312515146688/d914065dex31.htm"><font style="font-family:inherit;font-size:8pt;">Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K, filed on April 24, 2015).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000161061818000052/ex312018-05x21.htm"><font style="font-family:inherit;font-size:8pt;">Certificate of Designation of Preferences, Rights, and Limitations of Series X Convertible Preferred Stock (incorporated by reference to Exhibit 3.1 to the Registrant's Current Report on Form 8-K, filed on May 21, 2018).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.3</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000119312515146688/d914065dex32.htm"><font style="font-family:inherit;font-size:8pt;">Amended and Restated Bylaws of the Registrant, as currently in effect (incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K, filed on April 24, 2015).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.4</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000119312515119340/d843130dex41.htm"><font style="font-family:inherit;font-size:8pt;">Form of Common Stock Certificate of the Registrant (incorporated by reference to Exhibit 4.1 to the Registrant's Registration Statement on Form S-1 (File No. 333-202740), as amended, originally filed on March 13, 2015).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.5</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000119312516729294/d161044dex102.htm"><font style="font-family:inherit;font-size:8pt;">Form of Warrant to Purchase Common Stock issued to Pacific Western Bank (incorporated by reference to Exhibit 10.2 to the Registrant's Current Report on Form 8-K, filed on October 3, 2016).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.6</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000161061818000052/ex412018-05x21.htm"><font style="font-family:inherit;font-size:8pt;">Form of Common Stock Purchase Warrant for First Private Placement (incorporated by reference to Exhibit 4.1 to the Registrant's Current Report on Form 8-K, filed on May 21, 2018).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">4.7</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000161061818000052/ex422018-05x21.htm"><font style="font-family:inherit;font-size:8pt;">Form of Common Stock Purchase Warrant for Second Private Placement (incorporated by reference to Exhibit 4.2 to the Registrant's Current Report on Form 8-K, filed on May 21, 2018).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">5.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit51.htm"><font style="font-family:inherit;font-size:8pt;">Opinion of Cooley LLP.</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.1&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit231.htm"><font style="font-family:inherit;font-size:8pt;">Consent of Independent Registered Public Accounting Firm.&#160;</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">23.2&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="exhibit51.htm"><font style="font-family:inherit;font-size:8pt;">Consent of Cooley LLP. Reference is made to Exhibit&#160;5.1.</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">24.1&#160;&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="font-family:inherit;font-size:8pt;" href="#s5278DDD5340B52A28635EDC302C0BBB5"><font style="font-family:inherit;font-size:8pt;">Power of Attorney. Reference is made to the signature page hereto.</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000119312515131339/d909250dex992.htm"><font style="font-family:inherit;font-size:8pt;">2015 Equity Incentive Plan and Form of Grant Notice, Stock Option Agreement and Notice of Exercise thereunder (incorporated by reference to Exhibit 99.2 to the Registrant's Registration Statement on Form S-8 (File No. 333-203434), filed on April 15, 2015).</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">99.2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><a style="text-decoration:underline;color:#0000FF;-sec-extract:exhibit;" href="http://www.sec.gov/Archives/edgar/data/1610618/000119312515119340/d843130dex103.htm"><font style="font-family:inherit;font-size:8pt;">2015 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.3 to the Registrant's Registration Statement on Form S-1 (File No. 333-202740), as amended, originally filed on March 13, 2015).</font></a></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:1px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s5278DDD5340B52A28635EDC302C0BBB5"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:1px;text-align:left;"><hr></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:1pt;"><font style="font-family:inherit;font-size:1pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:2pt;"><font style="font-family:inherit;font-size:2pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:13px;text-align:left;text-indent:33px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form&#160;S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on </font><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font><font style="font-family:inherit;font-size:8pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:6%;"></td><td style="width:5%;"></td><td style="width:31%;"></td><td style="width:58%;"></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">CIDARA THERAPEUTICS, INC.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">By:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ Jeffrey Stein, Ph.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Jeffrey Stein, Ph.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">President and Chief Executive Officer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:27px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">POWER OF ATTORNEY</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:52px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Jeffrey Stein, Ph.D. and James Levine, and each of them, as his or her true and lawful attorneys-in-fact and agents, each with the full power of substitution, for him or her and in his or her name, place or stead, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective amendments), and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</font></div><div style="line-height:120%;padding-top:8px;text-align:left;text-indent:52px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:29%;"></td><td style="width:4%;"></td><td style="width:2%;"></td><td style="width:43%;"></td><td style="width:4%;"></td><td style="width:2%;"></td><td style="width:13%;"></td><td style="width:3%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Signatures</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Title</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;font-weight:bold;">Date</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ Jeffrey Stein, Ph.D</font><font style="font-family:inherit;font-size:8pt;">.</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Jeffrey Stein, Ph.D.</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">President, Chief Executive Officer and Member of the Board of Directors</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Principal Executive Officer)</font></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ James Levine</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">James Levine</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Chief Financial Officer</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-style:italic;">(Principal Financial Officer and Principal Accounting Officer)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ Scott M. Rocklage, Ph.D.</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Scott M. Rocklage, Ph.D.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Chairman of the Board of Directors</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ Daniel D. Burgess</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Daniel D. Burgess</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Member of the Board of Directors</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ Timothy R. Franson, M.D.</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Timothy R. Franson, M.D.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Member of the Board of Directors</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ David L. Gollaher, Ph.D.</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">David L. Gollaher, Ph.D.</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Member of the Board of Directors</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ Chrysa Mineo</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Chrysa Mineo</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Member of the Board of Directors</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;text-decoration:underline;">/s/ Theodore R. Schroeder</font></div><div style="text-align:center;padding-left:5px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Theodore R. Schroeder</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">Member of the Board of Directors</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">May&#160;9, 2019</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>exhibit51.htm
<DESCRIPTION>OPINION OF COOLEY LLP
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s130AF17CC23B598BB9D63A3FE3040FE2"></a></div><div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:34%;"></td><td style="width:33%;"></td><td style="width:33%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;"><img src="cooleylogoa03.jpg" alt="cooleylogoa03.jpg" style="height:44px;width:134px;"></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit 5.1</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Charles J. Bair</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">+1 858 550 6142</font></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">cbair@cooley.com</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;padding-top:24px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">May&#160;9, 2019</font><font style="font-family:Arial;font-size:11pt;">&#32;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Cidara Therapeutics, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">6310 Nancy Ridge Drive, Suite 101</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">San Diego, California </font></div><div style="line-height:120%;padding-bottom:16px;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Ladies and Gentlemen:</font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">You have requested our opinion, as counsel to Cidara Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;), with respect to certain matters in connection with the filing by the Company of a Registration Statement on Form S-8 (the &#8220;Registration Statement&#8221;) with the Securities and Exchange Commission, covering the offering of an aggregate of up to 1,390,800 shares of the Company's Common Stock, $0.0001 par value (the &#8220;Shares&#8221;), including 1,112,640 shares issuable pursuant to the Company&#8217;s 2015 Equity Incentive Plan (the &#8220;Incentive Plan&#8221;) and 278,160 shares issuable pursuant to the Company&#8217;s 2015 Employee Stock Purchase Plan (the &#8220;Employee Plan&#8221;).</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">In connection with this opinion, we have examined and relied upon the Registration Statement and related prospectuses, the Incentive Plan, the Employee Plan, the Company's Amended and Restated Certificate of Incorporation and Bylaws, and the originals or copies certified to our satisfaction of such records, documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render the opinion expressed below.  We have assumed the genuineness and authenticity of all documents submitted to us as originals and the conformity to originals of all documents submitted to us as copies thereof.  Our opinion is expressed only with respect to the General Corporation Law of the State of Delaware.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when issued and sold in accordance with the Incentive Plan or the Employee Plan, as applicable, the Registration Statement and related prospectus, will be validly issued, fully paid and nonassessable (except as to shares issued pursuant to certain deferred payment arrangements under the Incentive Plan which will be fully paid and nonassessable when such deferred payments are made in full).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4401 EASTGATE MALL, SAN DIEGO, CA 92121  T: (858) 550-6000  F: (858) 550-6420  WWW.COOLEY.COM</font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;"><img src="cooleylogoa03.jpg" alt="cooleylogoa03.jpg" style="height:41px;width:128px;"></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Cidara Therapeutics, Inc.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">May 9, 2019</font></div><div style="line-height:120%;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Page Two</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">We consent to the filing of this opinion as an exhibit to the Registration Statement.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Sincerely,</font></div><div style="line-height:120%;padding-top:16px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Cooley LLP</font></div><div style="line-height:120%;padding-top:48px;text-align:left;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">By:  </font><font style="font-family:Arial;font-size:11pt;text-decoration:underline;">/s/ Charles J. Bair</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;">Charles J. Bair</font></div><div style="line-height:120%;padding-top:16px;text-align:left;padding-left:48px;text-indent:-48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:11pt;"><font style="font-family:Arial;font-size:11pt;"><br></font></div><div><br></div><div style="text-align:center;"><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">4401 EASTGATE MALL, SAN DIEGO, CA 92121  T: (858) 550-6000  F: (858) 550-6420  WWW.COOLEY.COM</font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>exhibit231.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2019 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sABC0786653AA5F2CBB638A39A380E4D4"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Exhibit&#160;23.1</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:13px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">Consent of Independent Registered Public Accounting Firm</font></div><div style="line-height:120%;padding-top:9px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;color:#333333;">We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2015 Equity Incentive Plan and the 2015 Employee Stock Purchase Plan of Cidara Therapeutics, Inc. of our report dated February 28, 2019, with respect to the consolidated financial statements of Cidara Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2018, filed with the Securities and Exchange Commission.</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:120%;text-align:left;padding-left:336px;text-indent:96px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;color:#333333;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;padding-left:336px;text-indent:48px;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;color:#333333;">/s/ Ernst &amp; Young LLP</font></div><div style="line-height:120%;padding-top:17px;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">San Diego, California</font></div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">May&#160;9, 2019</font><font style="font-family:inherit;font-size:11pt;">&#32;</font></div><div><br></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>cooleylogoa03.jpg
<TEXT>
begin 644 cooleylogoa03.jpg
M_]C_X  02D9)1@ ! 0( =@!V  #_VP!#  4#! 0$ P4$! 0%!04&!PP(!P<'
M!P\+"PD,$0\2$A$/$1$3%AP7$Q0:%1$1&"$8&AT='Q\?$Q<B)"(>)!P>'Q[_
MVP!# 04%!0<&!PX(" X>%!$4'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" &(!+ # 2(  A$! Q$!_\0
M&P ! 0$! 0$! 0            @'!@4$ PG_Q !*$  " 0,$  ,#"00&" 0'
M 0   0(#!!$%!A(A!Q,Q"")!%!46(S(W476S5H&5TB1A<82QM!@E,T)259/3
M%S0U4T-&97)SI,-B_\0 ' $!  $% 0$               4" P0&!P@!_\0
M0Q$  @$" @4(!@D#! ,  P    $" P0%$08A,4%1$A,B87&!D:$',G*QP=$4
M%3,T-4)24_ CLN$78H+")$.2HM+Q_]H # ,!  (1 Q$ /P"RP
M
M
M   "'O$K[QMS?F]W^M(N$A[Q*^\;<WYO=_K2([$?5B=%]'7WFM[*]YSX (HZ
MR   5#[)?W<ZA^;U/T:)L!C_ +)?W<ZA^;U/T:)L!/VWV43S_I/^+5_:  +Y
M @
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MTI<?>2Y8QEXSDZ RU)26:9J5:A5H3<*L7%K<UD_!@ 'TM
M
M                   A[Q*^\;<WYO=_K2+A(>\2OO&W-^;W?ZTB.Q'U8G1?
M1U]YK>RO><^ "*.L@  %0^R7]W.H?F]3]&B; 8_[)?W<ZA^;U/T:)L!/VWV4
M3S_I/^+5_:  +Y @
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MGUC&99RY*3H7RET9ZF<OQW0:I;1E7L6Y17Y7ZR[./O[2A0 2!ST
M
M                     $/>)7WC;F_-[O\ 6D7"0]XE?>-N;\WN_P!:1'8C
MZL3HOHZ^\UO97O.? !%'60  "H?9+^[G4/S>I^C1-@,?]DO[N=0_-ZGZ-$V
MG[;[*)Y_TG_%J_M  %\@0
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MZ8VDL2N$OUS_ +F  72,
M                                               !#WB5]XVYOS>[
M_6D7"0]XE?>-N;\WN_UI$=B/JQ.B^CK[S6]E>\Y\ $4=9   *A]DO[N=0_-Z
MGZ-$V Q_V2_NYU#\WJ?HT38"?MOLHGG_ $G_ !:O[0 !?($
M
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M0^SCV(\ZXW^)7'MS_N8 !=(L
M                                                   $/>)7WC;F
M_-[O]:1<)#WB5]XVYOS>[_6D1V(^K$Z+Z.OO-;V5[SGP 11UD   J'V2_NYU
M#\WJ?HT38#'_ &2_NYU#\WJ?HT38"?MOLHGG_2?\6K^T  7R!
M
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M&_Q*X]N?]S  +I%@
M                                           A[Q*^\;<WYO=_K2+A
M(>\2OO&W-^;W?ZTB.Q'U8G1?1U]YK>RO><^ "*.L@  %0^R7]W.H?F]3]&B;
M 8_[)?W<ZA^;U/T:)L!/VWV43S_I/^+5_:  +Y @
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M4Y_9GF4L)=2>&^*,VE=TZFI/)FDXIHGB6')SE#E16^.OQ6U>&1H  ,DUH
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M7.2Z6>4N4LM9><OMGL&Q48<B"B><\8O'>WU6OGGRI/+LV+RR  +A&@
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MSFD8E_55&UJU&\LHMY\,DRT0 ;(>;
M      8_[4&\/F?:M/;=E7XWVK9\[A/$J=M%^]G$DUS>(]IJ4541KES7H6MM
M5N;FM3H4*4'.I4J248PBEER;?227>2)O$O=-?>.\[_6ZCJ*A4GPM*<\_54(]
M0CC+2>/>:3QRE)KU,.]J\BGDMK-RT*PCZ=?\]-="GK[]R^/<<V "%.V
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MU)9*>J7M<>]>:SVLZ0 $@<\   !#WB5]XVYOS>[_ %I%PD/>)7WC;F_-[O\
M6D1V(^K$Z+Z.OO-;V5[SGP 11UD   J'V2_NYU#\WJ?HT38#'_9+^[G4/S>I
M^C1-@)^V^RB>?])_Q:O[0 !?($'G[DUBRV_H-[K6HSX6MG1E5GAI.6/2,<M)
MRD\12SVVE\3T#&_:OUZ=ALRQT*E*I&>JW+E4Q"+C*E2Q)Q;?:?.5)K'_  OO
MX.W6J<W!R)+![!XA?4K;]3U]FU^69.6Y-8O=P:]>ZUJ,^=U>5I59X;:CGTC'
M+;48K$4L]))? \\ UUO-YL]%0A&G%0BLDM2  !4#O/!_PWU#?FJN<W4M-%MI
MI7=VEVWZ^73STYM8[](IY><Q4OC\)=D7.^=U4M/XW%+3:/UE_=4HI^5##PLO
MKE)KBO7XO#466+HNEZ?HNE6^E:5:T[2RMH<*5*"ZBO\ %MO+;?;;;>6S-M+7
MG>E+8:3I9I1]61^C6_VK6W]*^?!=[W9_/M?;VC;8TJ.EZ%84[*T4Y3X1;DY2
M?K*4I-N3]%EM])+T2/4 )A))9(XU4J3JS<YMMO:WK;  /I0      <7XG^&^
MA;\MJ<KYU+34:$)1H7M%+DDT\1FG]N"D^6.GZX:R\R5O';6K;3UZMHVLV_E7
M%/WHRCW"K!^DX/XQ>'_9AII--*Z3@_&O85#?&V&J7F1U;3X5*NGN,EB<FEFE
M)-I8GQBLMKBTGG&4\*ZM547*CM]YNNBNE%3#ZL;>XEG1>KV>M=6>U=ZZXZ!^
MES0KVMS5MKFC4H5Z4W"I3J1<90DGAQ:?::?6#\R&.TIIK-   &H>S9NSZ/;\
MAI=Q/%CK7&VGU]FLF_)EU%M]R<,92^LR_LE8G\_BX?#G<7TKV1I>ONEY52ZH
M_6P4>*52,G"?%9?N\HRQEYQC/9*X?5S3@]QRGT@X6J=6%]!>MT9=JV/O6:[D
M=  "1.;@E[VH-G_,^ZJ>Y+*AQL=6SYW"&(T[F*][.(I+FL2[;<I*HRH3F_$O
M:U#>.S+_ $2HJ:KU(<[2I/'U5>/<)9PVEGW6TL\922]2Q<TN=IM;R>T;Q9X7
M?PJM]%ZI=C^6TB('Z7-"O:W-6VN:-2A7I3<*E.I%QE"2>'%I]II]8/S( ] )
MIK-    K'V;-V?2'8<-+N)YOM%XVT^OM46GY,NHI+J+AC+?U>7]HDXU#V;-V
M?1[?D-+N)XL=:XVT^OLUDWY,NHMON3AC*7UF7]DR;2IR*JSV,UC2_#?IV&3Y
M*SG#I+NV^6>K>\BL0 3IP@      'SZG>VVFZ;<ZC>U?*M;6C.M6GQ<N,(IR
MD\++>$GTCZ#'_:@WA\S[5I[;LJ_&^U;/G<)XE3MHOWLXDFN;Q'M-2BJB+=6H
MJ<')DAA5A/$+NG;0_,]?4M[[D3MO77[G=&ZM1U^[CPJ7E9S4,I^7!)1A#*2S
MQBHQSCO&7VSQP#76VWFST72I0HPC3@LHI9)<$M@  *P:A[-FT_I#OR&J7$,V
M.B\;F??VJS;\F/4DUW%SSAKZO#^T9>6#[/NW?H]X9:?SJ^96U/\ UC4Q+,8^
M9&/!+I->Y&&5W[W+#Q@RK.ESE37L1JNF.*.PPV2@^E/HKOVOP\V:  "<.%G\
M_@ :R>G@   =Y[/M>A;^,&@U+BM3HP<ZT%*<E%.4J-2,8Y?Q<FDE\6TC@SH/
M#7[QML_F]I^M$KI/*:?68.*4U5LJU-[XR7BF7" #8SS>
M                    97[36YH:+L!Z12J5(7NLS\F'"<H.-*+C*J\I8::X
MP<6UE5'ZI-$I&L>U-K'R_P 2(Z;"=QY>F6=.E*G-^XJD_K'*"S\8RIIO";XX
M]$C)R"O*G+JOJU'=M#[!6>%4WEKGTGW[/+(  QC:  ?9H>G5]7UJQTFVE3A7
MO;FG;TY5&U%2G)13;2;QE_@PEF?)R4(N4MB-H]F'8,+VY>]=6MZ=2VH3=/3J
M56G+WJL6LUUGIJ/<5Z^]R?3@LT:?/IEE;:;IMMIUE2\JUM:,*-&')RXPBE&*
MR\MX27;/H-@H4E2AR4>><;Q:IBMW*O/9L2X+<OGU@ %XB            #-_
M:!V14W?M!7%C'.IZ5SN+>*C*3K0<?K*45'_>EQBUT^XI=<FR1C^@))7M$[,H
M;4WG&[TZVIV^E:K!UJ%.FE&-*I'"J02RWC+C+T27/BE[I&7]'_V+O.GZ XUK
M>'57Q<?>U\?$S, $8=/   -@]E;<7S;O>XT"=+E3UBC[LU'+C4HQG-9>5B+B
MZF>F\\?19*A(*T/4:^D:U8ZM;1ISKV5S3N*<:B;BY0DI)-)IXROQ1>-M7H75
MM2N;:M3KT*L%.G4IR4HSBUE237337>27P^IG!QX'(/2!8*C>0N8_^Q:^V.KW
M9>!^@ ,\T &#>UIN6I0L]+VI:W''Y3F[O(+DFX1?&DF_LN+DIMKONG%]=9WD
MBKQAUFAK_B9KNIVWENA*Y\FG*G552-2-**IJ:DNFI*'+]_J_4P[ZIR:>2WFY
MZ#8>KK$N=DM5-9]^Q?%]QR8 (4[6   "C/9L\-X6=M:[ZU9U/E=:$GIUOB4/
M*A).+J2SCDY1;XK[/&2?;:XXOX:;6K[QWG8:)3514*D^=W4AGZJA'N<LX:3Q
M[J;6.4HI^I;-M0H6MM2MK:C3H4*4%"G3IQ48PBEA1272276"0L:*D^6]QSW3
MO&Y6U)65%Y2FNE[.S+O]RZS]  2QR,            &3^T/X=_2C1GN'2J-Q
M5UO3Z*A&C2][Y314FW#BW]J/*4ECM]QPVXXU@%%2FJD7%F=AV(5L/N8W%%ZU
MYK>GU,_G\#0/'K9_T2WY<?):'EZ9J.;JSXPQ"&7[]-8BHKC+TBLXC*&?4S\U
MZ<'"3B]QZ&LKNG>6\+BGLDL_YV;  "DR@;9[*&YH66XK[:]S4J<-2@JUJG.3
MC&K33<DHXPG*';EE?[)+O*QB9U'A-K'S%XD:#J3G;TZ<;R-*K4KO$(4ZGU<Y
M-Y6,1G)Y;PL9?1=H3Y%1,B<>LE>X=6HM9MQ;7:M:\T6R #83SN   "'O$K[Q
MMS?F]W^M(N$A[Q*^\;<WYO=_K2([$?5B=%]'7WFM[*]YSX (HZR   5#[)?W
M<ZA^;U/T:)L!C_LE_=SJ'YO4_1HFP$_;?91//^D_XM7]H  OD""0O:*UZ&N>
M*-]&C*G.AIL(V%.482BVX-N:EGU:J2J1RL+"6,^KK'7-1H:1HM]JUS&I.A96
MU2XJ1II.3C"+DTDVEG"_%$'7->O=7-6YN:U2O7JS<ZE2I)RE.3>7)M]MM]Y(
M[$)Y143HWH\LE.XJW3_*DEVO;X)>9^8 (HZP #[-#M*&H:U8V%S>4[&A<W-.
MC4N:F.-&,I).;RTL)//JO3U02S/DY*$7)[$5;[.FVJ>@^&]I=U+?R[[5OZ77
MD^+;@_\ 9)./?'AB23;PYR],X6D'/_3C97[7[?\ XE1_F'TXV5^U^W_XE1_F
M-AI\B$5%/8>=[^-Y>W,[B=.6<FWL>KJ[MAT .?\ IQLK]K]O_P 2H_S#Z<;*
M_:_;_P#$J/\ ,5\N/$Q/H-S^W+P9T .?^G&ROVOV_P#Q*C_,/IQLK]K]O_Q*
MC_,.7'B/H-S^W+P9T .?^G&ROVOV_P#Q*C_,/IQLK]K]O_Q*C_,.7'B/H-S^
MW+P9T .?^G&ROVOV_P#Q*C_,/IQLK]K]O_Q*C_,.7'B/H-S^W+P9T .?^G&R
MOVOV_P#Q*C_,/IQLK]K]O_Q*C_,.7'B/H-S^W+P9@WM3[2MM*UZRW)IUKY-'
M4^<+M4Z34%7CWS<LX4IIOK"SY<I=MMF+E0^T'KNSM<\+[ZC:Z_H]_?6]:C6M
M*5"_A.?/S%"348RS+W)SZP_Q^&27B%O(QC5?)WG;-#KFM7PR,:Z:E!N.O>EK
M7D\NX  Q3: 4[[)NJ0N=CZAI4[JI5KV5\YJE)R:I4JD(\>.>DG.-5X7QRWZ]
MS$:Q[+.L?(/$B6FSG<>7J=G4I1IP?N.I#ZQ2FL_",:B3PVN6/1LR;2?)JKK-
M:TOL_I6$U4ML>EX;?+,JD $Z<&   )>]J#9_S/NJGN2RH<;'5L^=PAB-.YBO
M>SB*2YK$NVW*2J,Q\MWQ+VM0WCLR_P!$J*FJ]2'.TJ3Q]57CW"6<-I9]UM+/
M&4DO4B(A+VER*F:V,[=H5BSOK#FIOI4\EW?E^7<  8AN   !:/@[NSZ8[#LM
M4K3Y7U+^C7W6/KH)9E]E+WDXSQ%87+'P.P).]FS=GT>WY#2[B>+'6N-M/K[-
M9-^3+J+;[DX8RE]9E_9*Q)ZUJ\[33>TX)I3A'U9B$H170ETH]CW=SU=F7$
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M?)J-O>3^3TN?/C1D^5+O+;]R47V\_CWDY\UJ2<6TSTS0K1KTHU8;))-=CU@
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MK3[N=/\ S>G^C6)>(:_>=7+J.SZ T8PPQS6V4GY9+^=H !A&[@
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M2SQDI1SCO&5TR6L*N<7![CD>G^%NE<QO8^K/4_:2U>*]S/8 !('/0
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MVT,26"T?^7]T@ #&-H                              /Z @ V8\P@
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M&P0FIQ4EL//EY:5;*O*A664HO)_S@]JZ@ "HQ@
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M/\IT '(CP'TZY_<EXLY_Z#[*_9#;_P##:/\ */H/LK]D-O\ \-H_RG0 <B/
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M6WA+DXOM)O')1<C2":A.,URHLXE?6-Q8UG1N(\F2_F:XH  K,0
M      'SZC?66FV=2]U&\M[.UIXYUJ]54X1RTEF3:2RVE^\'V,7)I)9MGT$Y
M>.7C%.]J7.V-I7%-V#A.A?7JC&:N5*+C*G3RFN&&_?7;?V6DLR^/QI\9OI#9
MU-O[4=Q;Z;4Y0N[J<>$[F.6N$%ZQIM=O.)2SAJ*RI8N15U>9]"F^\ZIHIH?S
M35W?QZ7Y8O=UOKX+=M>O98/LZ_<YH7]X_P Q5- ,_P#9U^YS0O[Q_F*IH!(4
M/LX]B.?8W^)7'MS_ +F  72+)2]J#1J^G^)D]3EYDZ&JVU.M"3I.,8RA%4Y0
M4O232A&3],<UUZ-Y653[4&VJFL[#IZM:V_FW6CUG5DUR<E0DL5,164\-4Y-O
MTC"3RNTY6(*[I\BJ^O6=WT0OU>853UZX=%]VSRR  ,8V<'V:'J-?2-:L=6MH
MTYU[*YIW%.-1-Q<H24DFDT\97XH^,!/(^3BIQ<9;&7CMO6++<&@V6M:=/G:W
ME&-6&6FXY]8RPVE*+S%K/337P/0)R]F'?T+*Y>RM6N*=.VKS=33JM6I+W:LF
MLT%GI*7<EZ>]R7;FL4:;!0JJK!2//6.X3/"[R5"2Z.V+XK=\GU@ %XAP
M        2%[0&\:&[M\25A.I+3M-@[2B_.4Z=62F^=:"724NDFF\QA%O\%MO
MM#[Z^BVU7I>F7WDZWJ.(T_*J8JT*.7SJ^CQG'!/*>9-Q>8,DXB[^M_ZUWG4=
M L%<4\0JKJC\7\%W@ $:=-   /LT/3J^KZU8Z3;2IPKWMS3MZ<JC:BI3DHIM
MI-XR_P &7;IEE;:;IMMIUE2\JUM:,*-&')RXPBE&*R\MX27;)B]E?09ZCO\
MJZU.-14-)MI24XSBEYM5.$8R3[:</-?7HXK+^#J4EL/IY0<N)R'T@W_.WD+6
M+U06;[9?XR\0 "0.?@B;Q9T?YB\2->TU0MZ=.-Y*K2IT%B$*=3ZR$4L+&(SB
ML)86,+HMDG[VM]N_^D[LIU?_ *=6IRE_]]2FXK'_ .3+;_X<+U,*^I\JGGP-
MUT$OU;8CS,ME19=ZUKXKO)_ !#':0  #I/#3=-?9V\[#6Z;J.A3GPNZ<,_6T
M)=3CC*3>/>2;QRC%OT+9MJ]"ZMJ5S;5J=>A5@ITZE.2E&<6LJ2:Z::[R0$4)
M[+^_:'R:&P]0\Q5U.I5TVHHIQ<<.<Z3PLII\YIO.<M96(IY]C7Y+Y#WG/M.L
M$=S15]272@NE[/'N]S? WT $N<B             !C?M(^(5#1]%K;2TFZIS
MU6^APO4H*?D6\HO,6\XC.::PL-J+;ZS%NW5J*G%R9GX9AU;$KF-O26M[^"WM
M]2,B\>MX?2W?EQ\EK^9IFG9M;/C/,)X?OU%B3B^4O22QF,89]#/P#7YS<Y.3
MWGH6RM*=G;PMZ>R*R_G;M  *3*!TGA=I<]9\1= T^-K3NX3OJ4ZU&HHN,Z4)
M<ZF5+IKA&77Q]._0YLVCV4MM5+W=5WN:O;YM=.HNE0J2Y+Z^HL/CCW98I\TT
MWUYD7CM-7:$.742(K'+Q66'UJS>R+R[7J7F4R #83SL   "'O$K[QMS?F]W^
MM(N$A[Q*^\;<WYO=_K2([$?5B=%]'7WFM[*]YSX (HZR   5#[)?W<ZA^;U/
MT:)L!C_LE_=SJ'YO4_1HFP$_;?91//\ I/\ BU?V@ "^0)X^]M'^D&T-7T50
MMYU+RSJ4J7GK,(U'%\)/IXXRXRREE8RNT0L?T!(N\9MO_1KQ(U>PITO+M:E;
MY3:J-#RH>74]Y1@O3C%MPRNO<?IZ*-Q&&I2.E^CN]2G6M6]N4EW:G[T<> "+
M.I@  %H^#.X/I+X;Z1?U*OF75.C\FNG*OYL_,I^ZY3?KRDDIX??OKU]7V!+7
MLS[VAH&YY[>U"M45AJ\X0H84I*G=948=)XBII\6\-Y4,X2;*E)ZVJ\Y33WG
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M]XE?>-N;\WN_UI$=B/JQ.B^CK[S6]E>\Y\ $4=9   *A]DO[N=0_-ZGZ-$V
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M$^XQ?]4I=X4<K (:I4E4ERI':</P^AA]"-"A'**\6^+ZS0/##Q6W!LGA9?\
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MKY=3'2FEGOTDEE8Q)1X,A)P<'R9;3M]G>4;VC&O0EG%_SQ  *3)
M/0T?7-:T;S?F?6-0T[SL>;\EN9TN>,XY<6LXR\9_%GH?3C>O[7[@_B5;^8Y\
M'U2DMC+$[6A4ERIP3?6D=!].-Z_M?N#^)5OYCGP Y-[654Z%*EGS<4L^"R
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M&4))X<6GVFGU@AZM&=)Y21V+#,8M,4I\Y;3SXK>NU?Q<#\P 6R3
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MDO1(]0F+:U5+6];.-:1Z4UL7ES5/.-);M[ZW\MBZP #+-3
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M1RGW)9:Y,T  SH0C!9161HUW>W%Y4YRXFY/K_FKN  *C%
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M*EPFN+S3A]F&)1RGW)9:Y,T  SH0C!9161HUW>W%Y4YRXFY/K_FKN  *C%
M             !S_ (C;B^BFR-4U]4O-J6M'ZJ#CR3J2DH0Y+*]WE*.</.,X
M[.@)N]JW=GRS6;39]K/ZFPQ<WG7K6E'W(]QS[L)9RFT_,P^XEBXJ\U3<B;T=
MPMXGB%.CET5KE[*V^.SM9B=S7KW5S5N;FM4KUZLW.I4J2<I3DWER;?;;?>3\
MP" /0:22R0   -L]E#;,+W<5]NBYIU.&FP5&U;A)1E5J)J34LX;C#IQP_P#:
MI]86<7MJ%>ZN:5M;4:E>O5FH4Z=.+E*<F\**2[;;ZP6SX:;6H;.V98:)35-U
MZ<.=W4ACZVO+N<LX3:S[J;6>,8I^AF65+EU.4]B-,TWQ16>'NA%]*IJ[OS>.
MSO.D !-'%
M
M
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MHPS%X?'/Q.P)ZUI<U32>TX%I1BJQ/$9U(/H1Z,>Q;^]YOL  ,@UX
M
M
M
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M@
M
M
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M:8
M
M
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ML  'P
M
M
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M@^C3V^T_DO-M  &>:"
M
M
M                                                3][5N\/_ "FR
M[&O^%UJ'"?\ TZ;Q+^V;C)?^VT3^ 0%U)RJO,[]HM;4[?"J*@O67*?:];_G
M  L&P _2VH5[JYI6UM1J5Z]6:A3ITXN4IR;PHI+MMOK  2S914DXP<EN1<NR
MM MMK[5T[0+27.G9T5!SPUYDVW*<\-O'*3E+&>LX72/8 -E2262/-%6K.M.5
;2;S;>;?%O:  ?2V                  ?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
